| Literature DB >> 29398651 |
Liam Chung1, Erik Thiele Orberg2, Abby L Geis2, June L Chan3, Kai Fu4, Christina E DeStefano Shields2, Christine M Dejea5, Payam Fathi5, Jie Chen3, Benjamin B Finard6, Ada J Tam6, Florencia McAllister2, Hongni Fan6, Xinqun Wu5, Sudipto Ganguly6, Andriana Lebid6, Paul Metz7, Sara W Van Meerbeke5, David L Huso8, Elizabeth C Wick9, Drew M Pardoll6, Fengyi Wan10, Shaoguang Wu5, Cynthia L Sears11, Franck Housseau12.
Abstract
Pro-carcinogenic bacteria have the potential to initiate and/or promote colon cancer, in part via immune mechanisms that are incompletely understood. Using ApcMin mice colonized with the human pathobiont enterotoxigenic Bacteroides fragilis (ETBF) as a model of microbe-induced colon tumorigenesis, we show that the Bacteroides fragilis toxin (BFT) triggers a pro-carcinogenic, multi-step inflammatory cascade requiring IL-17R, NF-κB, and Stat3 signaling in colonic epithelial cells (CECs). Although necessary, Stat3 activation in CECs is not sufficient to trigger ETBF colon tumorigenesis. Notably, IL-17-dependent NF-κB activation in CECs induces a proximal to distal mucosal gradient of C-X-C chemokines, including CXCL1, that mediates the recruitment of CXCR2-expressing polymorphonuclear immature myeloid cells with parallel onset of ETBF-mediated distal colon tumorigenesis. Thus, BFT induces a pro-carcinogenic signaling relay from the CEC to a mucosal Th17 response that results in selective NF-κB activation in distal colon CECs, which collectively triggers myeloid-cell-dependent distal colon tumorigenesis.Entities:
Keywords: Nf-κB; STAT-3; colorectal cancer; inflammation; mucosal immunology; myeloid cells
Mesh:
Substances:
Year: 2018 PMID: 29398651 PMCID: PMC5954996 DOI: 10.1016/j.chom.2018.01.007
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023